Evaluation of inflammatory cytokines in malignant and benign pleural effusions

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1327-1332

  Alexandrakis, Michael G ^a   Coulocheri, Stavroula A ^b   Bouros, Demosthenes ^a,c   Mandalaki, Kiriaki ^a   Karkavitsas, Nikolaus ^a   Eliopoulos, George D ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Cytokincs; Exudate; Lung cancer; Pleural effusion; Tumor markers

Indexed keywords

INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PLEURA EFFUSION; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; LEUKOCYTE COUNT; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034320267     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1327     Document Type: Article

References (32)

1. Gjomarkaj M, Pace E, Melis M, Spatafora M and Toews GB: Mononuclear cells in exudative malignant pleural effusions: characterization of pleural phagocytic cells. Chest 106: 1042-1049, 1994.
2. Antony VB, Godey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD and Strieter RM: Recruitment of inflammatory cells to the pleural space. J Immunol 151: 7216-7223, 1993.
3. Light RW, Erosan YS and Ball CW: Cells in the pleural fluid: their value in differential diagnosis. Arch Intern Med 132: 854-860, 1973.
4. Monti G, Jaurand MC, Monnet I, Chretien P, Saint-Etienne L, Zeng L, Portier A, Devillier P, Galanand P, Bignon J and Emilie D: Intrapleural production of interleukin-6 during mesothelioma and its modulation by γ-interferon treatment. Cancer Res 54: 4419-4423, 1994.
5. Schimokata K. Saka H. Murate T, Hasegawa Y and Hasegawa T: Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest 99: 1103-1107, 1991.
6. Yokoyama A, Kohno N, Fujino S. Hamada H, Inoue Y, Fujioka S and Hiwada K: Origin of heterogeneity of interleukin-6 (IL-6) levels in malignant pleural effusions. Oncol Rep 1: 507-511, 1994.
7. Hoheisel G, Izbicki G, Roth M, Chan CHS, Reichenberger F, Schauer J and Perruchoud AP: Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65: 183-186, 1998.
8. Ishii Y, Uchiyama Y, Hasegawa S, Kinoshita T, Mitsui K, Kojima H and Fujita T: Detection of tumour necrosis factor/ cachectin in pleural effusion of patient with lung cancer. Clin Exp Immunol 80: 350-353, 1990.
9. Mizuno K, Son S, Orino E, Mucaida N, Matsuchima K and Ogura T: Spontaneous production of interlcukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levels. Oncology 51: 467-471, 1994.
10. Suda T, Miura Y, Mizoguchi H, Kubota K and Takaku F: A case of lung cancer associated with granulocytosis and production of colony-stimulating activity by the tumor. BrJ Cancer 41: 980-984, 1980.
11. Ogawa K, Koga H, Hirakata Y, Tomono K, Tashiro T and Kohno S: Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion. Tuber Lung Dis 78: 29-34, 1997.
12. Alexandrakis M, Coulocheri S, Kyriakou D, Bouros D, Xirouhaki N, Siafakas N, Castanas E and Eliopoulos GD: Diagnostic value of ferritin, haptoglobin, al-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation. Respir Med 91: 517-523, 1997.
13. Weissflog D, Kroegel C, Luttman W, Grahmann PR and Hasse J: Leukocyte infiltration and secretion of cytokines in pleural dranage fluid after thoracic surgery: impaired cytokine response in malignancy and postoperative complications. Chest 115: 1604-1610, 1999.
14. Nakano T, Chahinian AP, Shinjo M, Tonomura A, Miyake M, Togawa N, Ninomiya K and Higashino K: Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. BrJ Cancer 77: 907-912, 1998.
15. Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153-205, 1989.
16. Fujiwara H, Kleinhenz ME, Wallis RS and Ellner JJ: Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 133: 73-77, 1986.
17. Waldman TA: The interleukin-2 receptor. Biol Chem 226: 2681-2684, 1991.
18. Rchermann B, Trautwein C, Boker KHW and Manns MP: Interleukin-6 in liver disease. J Hepatol 15: 277-280, 1992.
19. Kishimoto T: The biology of interleukin-6. Blood 74: 1-10, 1989.
20. Yokoyama A, Maruyama M, Itto M, Kohno N, Hiwada K and Yano S: Interleukin-6 activity in pleural effusion: its diagnostic value and thrombopoietic activity. Chest 102: 1055-1059, 1992.
21. Blay JY, Favrot M, Rossi JF and Wijdenes J: Role of interleukin-6 in paraneoplastic thrombocytosis. Blood 83: 2261-2262, 1993.
22. Strassmann G, Fong M, Kenney JS and Jacob CD: Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J CJin Invest 89: 1681-1684, 1992.
23. Takizawa H, Ohtoshi T, Ohta K, Yamashita N, Hirohata S, Hirai K, Hiramatsu K and Ito K: Growth inhibition of human lung cancer cell lines by interleukin-6 in vitro: a possible role in tumour growth via an autocrine mechanism. Cancer Res 53: 4175-4181, 1993.
24. Baggiolini M, Walz A and Kunkel SL: Ncutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophil. J Clin Invest 84: 1045-1049, 1989.
25. Wilkinson PC and Newman I: Identification of IL-8 as a locomotor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of mycobacterium tuberculosis. J Immunol 149: 2689-2694, 1992.
26. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B and Baggiolini M: Phagocytosing neutrophils produce and release high amounts of the neutrophil activating peptide 1/interleukin-8. J Exp Med 171:773-774, 1991.
27. Goodman RB, Wood RG, Martin TR, Hanson-Painton O and Kinasewitz GT: Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/ IL-8. J Immunol 148: 457-465, 1992.
28. Miller EJ and Idell S: Interleukin-8: an important neutrophil chemotaxin in some cases of exudative pleural effusions. Exp Lung Res 19: 589-601, 1993.
29. Nathan CF: Secretory products of macrophases. J Clin Invest 79: 319-325,1987.
30. Teng MN, Par BH, Koeppen HKW, Tracey KJ, Fendly BM and Schreiber H: Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc Natl Acad Sci USA 88: 3535-3539, 1991.
31. Balkwill F, Burke F, Talbot D, Tavernier J, Osborne R and Naylor S: Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 2: 1229-1232, 1987.
32. Noldawer LL, Georgieff N and Lundholm KG: Interleukin-1, tumour necrosis factor-alpha and the pathogenesis of cancer cachexia. Clin Physiol 7: 263-274, 1987.